rawfin.tv
Olema Pharmaceuticals Q2 EPS Misses Estimates, Losses Widen
EarningsstocksAI Generated

Olema Pharmaceuticals Q2 EPS Misses Estimates, Losses Widen

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Olema Pharmaceuticals reported a Q2 EPS of $(0.61), missing the analyst consensus of $(0.55) by 10.91%. The company's losses widened during the quarter, indicating ongoing financial challenges.

OLMAEarnings MissQ2 ResultsPharmaceuticals SectorFinancial Performance

Related Articles

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

China Equities Lag US Stocks by Record 2.095 Valuation Ratio

stocks
S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

S&P 500 Faces 30% Drop in $20T AI Bust, TS Lombard Warns

stocks
Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

Nasdaq Smashed and Dow Drops as Oil Jumps on Geopolitical Tensions

stocks
Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

Asian Equities Plunge And Bitcoin Retreats As Chinese Markets Enter Bear Territory

stocks